Anupam B. Jena, MD, PhD, the Ruth L. Newhouse Associate Professor of Health Care Policy at Harvard Medical School and a faculty research fellow at the National Bureau of Economic Research, discusses using creative thinking to devise natural experiments that can help guide health care and spending.
Rebecca Miksad, MD, MPH, a senior medical director of Flatiron Health, medical oncologist and health outcomes researcher, discusses how real-world data address regulatory and drug development challenges.
Leaders from the Massachusetts Consortium on Pathogen Readiness (MassCPR) discuss evolving priorities, progress, and the influence of their collaborative work on public policy and re-opening strategies in the wake of COVID-19.
Jagpreet Chhatwal, PhD, an assistant professor at Harvard Medical School and decision scientist at MGH Institute for Technology Assessment, discusses the challenges of building an interactive COVID-19 modeling tool and its real-world impact.
Robert M. Plenge, MD, PhD, senior vice president of research and early development, and head of the immunology, cardiovascular, fibrosis and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
Lauren Orefice, PhD, assistant professor in the Department of Genetics at the Blavatnik Institute at Harvard Medical School, discusses steps toward translating promising science into novel treatments for autism.
A conversation with Stanley Y. Shaw, associate dean for Executive Education, about trends impacting health care, the importance of understanding the inner workings of the industry and how business leaders can create new value.
J. Michael McWilliams, MD, PhD, the Warren Alpert Foundation Professor of Health Care Policy at the Blavatnik Institute at Harvard Medical School and an internist at Brigham and Women’s Hospital, discusses hospital readmissions and pay-for-performance measures.
David Y. Ting, chief medical information officer of the Massachusetts General Physicians Organization in Boston and co-director of the MGH Center for Innovation in Digital HealthCare, discusses technologies aimed at easing administrative burden and provider burnout.
Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.